Table 3

JACC: Cardiovascular Interventions

Volume 9, Issue 1, January 2016 DOI: 10.1016/j.jcin.2015.09.024

Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold
A Systematic Review and Meta-Analysis

Michael J. Lipinski, Ricardo O. Escarcega, Nevin C. Baker, Hadiya A. Benn, Michael A. Gaglia Jr., Rebecca Torguson and Ron Waksman

Table 3

Lesion and Procedural Characteristics for Lesions Treated With a BVS

Study	AHA/ACC Lesion Class, %				LAD, %	LCX, %	RCA, %	Total Scaffold Length, mm	Lesion Length, mm	Pre-BA, %	Post-BA,%	Baseline RVD	Baseline MLD	Baseline %DS	Post In-Scaffold MLD	Post % DS
Study	A	B1	B2	C	LAD, %	LCX, %	RCA, %	Total Scaffold Length, mm	Lesion Length, mm	Pre-BA, %	Post-BA,%	Baseline RVD	Baseline MLD	Baseline %DS	Post In-Scaffold MLD	Post % DS
ABSORB	1	55	40	4	43	24	34	12 ± 0	9.9 ± 3.6	100	NR	2.61 ± 0.37	1.06 ± 0.28	59 ± 10	2.27 ± 0.26	15 ± 6
ABSORB II	1	53	44	2	45	29	26	21.1 ± 8.8	13.8 ± 6.5	100	61	2.59 ± 0.38	1.07 ± 0.32	59 ± 11	2.22 ± 0.33	16 ± 7
ABSORB EXTEND	2	53	42	3	45	26	28	NR	12.3 ± 5.3	NR	NR	2.65 ± 0.39	1.11 ± 0.32	58	NR	NR
ABSORB FIRST	17	35	23	24	51	21	28	NR	18.5 ± 9.3	94	47	3.05 ± 0.45	0.58 ± 0.44	81 ± 13.6	NR	2.2 ± 6.3
AMC	17	16	42	25	60	15	23	NR	NR	98	55	2.34 ± 0.67	0.79 ± 0.46	68 ± 18	2.16 ± 0.42	18 ± 7
ASSURE	13	22	43	21	42	22	24	NR	11.6 (9.3–16.5)	99	13	2.6 ± 0.5	0.9 ± 0.5	64.6 ± 15.1	2.5 ± 0.4	16.1 ± 7.7
BVS-EXAMINATION	NR	NR	NR	NR	45	13	41	22.2 ± 9.0	NR	81	36.3	NR	NR	NR	NR	NR
BVS EXPAND	NR	NR	NR	NR	NR	NR	NR	NR	25.4 ± 13.5	92	47	NR	NR	NR	NR	17.5 ± 8.45
BVS-RAI	NR	NR	NR	NR	61	13	27	18 (18,28)	NR	94	94	NR	NR	99	NR	NR
BVS STEMI	NR	NR	NR	NR	43	12	45	26.4 ± 13.9	NR	67	20	2.78 ± 0.70	0.38 ± 0.31	85.4 ± 8.8	2.44 ± 0.49	14.7 ± 8.2
CTO-ABSORB	0	0	0	100	40	11	46	52.5 ± 23.0	35.9 ± 15.8	100	63	2.99 ± 0.34	0 ± 0	100	2.41 ± 0.38	13.9 ± 3.6
EVERBIO II	20	51	14	16	46	25	25	22.8 ± 8.8	NR	97	34	2.77 ± 0.60	0.60 ± 0.58	81.3 ± 16.2	2.56 ± 0.43	9.3 ± 5.7
GABI-R	21.9	37.6	22.5	18	68	45	50	27.6 ± 17.0	NR	93	67	NR	NR	NR	NR	NR
GHOST-EU	22	27	24	28	47	25	25	32.6 ± 23.0	19.4 ± 14.4	98	49	3.0 ± 0.5	NR	NR	NR	NR
POLAR-ACS	6	33	40	21	48	27	21	23.4 ± 11.0	15.6 ± 5.9	93	75	2.8 ± 0.5	NR	65.6 ± 17.6	2.3 ± 0.4	13.1 ± 8.47
PRAGUE-19	NR	NR	NR	NR	40	23	37	23.7 ± 12.0	NR	85	33	2.80 ± 0.38	NR	NR	2.78 ± 0.29	NR
REPARA	19.2	38.7	26.6	14.7	51	22	27	23.0 ± 13.3	NR	78	40	NR	NR	NR	NR	NR
Robaei et al.	10	34	19	37	42	13	42	22.7	20.9 ± 13.0	100	95	2.8 ± 0.5	0.89 ± 0.59	79.48 ± 11.3	NR	NR
Costopoulos et al.	NR	NR	NR	NR	63	23	13	NR	NR	98	99	NR	NR	NR	NR	NR
Gori et al.	NR	NR	NR	NR	42	19	38	19.4 ± 4.6	NR	100	14	NR	NR	NR	NR	NR
Jaguszewski et al.	24	34	24	17	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR	NR
Kajiya et al.	NR	NR	NR	NR	64	18	18	NR	NR	NR	91	NR	NR	NR	NR	NR
Mattesini et al.	0	0	36	64	68	8	22	NR	24.7 ± 14.2	100	100	2.7 ± 0.4	0.8 ± 0.4	NR	2.7 ± 0.4	NR
Ojeda et al.	0	0	0	100	48	24	28	43 ± 21	35 ± 19	100	100	3.03 ± 0.4	0 ± 0	100	2.7 ± 0.4	11 ± 6
Wiebe et al.	NR	NR	NR	NR	48	36	16	NR	NR	NR	13%	NR	NR	NR	NR	NR
Weighted mean	16	37	28	19	53	28	32	26 ± 15	17 ± 10	91	52	2.84 ± 0.46	0.83 ± 0.39	71 ± 13	2.36 ± 0.37	10 ± 7

Values are mean ± SD or median (interquartile range) unless otherwise indicated.

ACC/AHA = American College of Cardiology/American Heart Association; BA = balloon angioplasty; %DS = percentage diameter stenosis; LAD = left anterior descending coronary artery; LCX = left circumflex coronary artery; MLD = minimal luminal diameter; NR = not reported; RCA = right coronary artery; RVD = reference vessel diameter.

User menu

Scaffold Thrombosis After Percutaneous Coronary Intervention With ABSORB Bioresorbable Vascular Scaffold
A Systematic Review and Meta-Analysis

Table 3

JACC: Cardiovascular Interventions

JACC Journals

General Information

American College of Cardiology